F. Quinolones and Chloramphenicol

download report

Transcript F. Quinolones and Chloramphenicol

How to download Accelrys DS
2. Click on Learn more and request a free copy of
Discovery Studio Visualizer
3. Complete the form to receive your free version of DS
4. You will receive an email from the company
containing the link to download the software.
Synthetic antibacterial agents
 First, isolated from streptomyces bacteria in 1947.
 Due to its simple structure, nowadays it is widely
produced in large scale by chemical synthesis from Pnitroacetophenone.
 It has a bacteriostatic action, inhibiting bacterial
protein biosynthesis…. Believed to be through
inhibiting the elongation step.
 It has a broad spectrum of activity, but because of its
serious systemic toxicity (aplastic anemia), it is mainly
used topically for skin and eye infections.
 Active on both gram +ve and gram –ve bacteria, even
on penicillin resistant strains such as H.influenza, N.
meningititis and S. pneumonia.
 It has a good penetration to CNS… used in meningitis.
 Not recommended in UTI (why?)… only 5-10% of the
unmetabolized chloramphenicol is excreted in urine.
 Bacteria became resistant to chloramphenicol through
the production of chloramphenicol acyltransferase
which acylate the OH group at C1 and C3 to the
inactive esters.
Metabolism of Chloramphenicol
SAR of Chloramphenicol
 P-nitro group can be replaced by other aryl ring or
oxygenated functional group without great loss in
 Phenyl ring can accept multi-substitutions.
 Conversions of 1-OH to keto group causes appreciable
loss inactivity.
Chloramphenicol esters
 They have better physicochemical properties than
Chloramphenicol which has both bitter taste and bad
water solubility.
Quinolones antibacterial agents
 Nalidixic acid is the lead compound for this group.
 According to the heterocyclic core can be divided into:
 Naphthyridines: nalidixic acid and enoxacin.
 Quinolines: norfloxacin, ciprofloxacin, ofloxacin,
 Cinnolines: Cinoxacin
Quinolones antibacterial agents
 Spectrum of activity:
 Highly active against urinary tract pathogens such as E.
coli, Klebsiella, Citrobacter, proteus as well as salmonella
and shigella.
 Most except fluoroquinolones are not active on P.
aeruginosa and H. influenza.
 Inactive on anaerobic and gram +ve bacteria.
 Pharmacokinetics:
 They have good oral bioavailability.
 They reach urine in enough concentration to be effective
in UTI (>40%).
Quinolones antibacterial agents
 Mechanism of action:
Inhibit DNA synthesis by inhibiting DNA gyrase
(topoisomerase-II) which is important for DNA
 Transport into bacterial cell: mainly through the porin
channels of the gram –ve bacteria.
 Mechanisms of bacterial resistance:
 Mutation in porin channels.
 Energy dependant efflux mechanism.
SAR of Quinolones
 The carboxylic acid at C3 is essential for activity.
 Pyridone ring must be annulated with aromatic ring
such as in Naphthyridine, Quinolines and Cinnolines.
 Isosteric replacement of nitrogen for C2, C5, C6 or C8
resulted in retained activity.
 Substitution at C2 greatly reduces or abolishes activity.
 Positions 5,6,7 and 8 can be substituted for better
SAR of Quinolones
 Positions 5,6,7 and 8 can be substituted for better
 Piperazine ring and 3-aminopyrrolidine at C7 enhances
activity, mainly against P. aeruginosa.
 Fluorine atom at C6 also improved activity
 Alkyl substitution on C1 improves activity (but small
alkyl or aryl group).
 Ring condensation at 1-8, 5-6, 6-7 and 7-8 also lead to
better activity.
 They are 6-fluoro-7-piperazinoquinolones derivatives.
 They exhibit extended spectrum of activity that covers
most of gram +ve and gram –ve bacteria especially P.
 Members:
 Ciprofloxacin.
 Norfloxacin.
 Ofloxacin.
 Pefloxacin.
 Lomefloxacin.
 Enofloxacin.
 Levofloxacin.
Chemical structure of
 Have an acidic (3-carboxylic acid) and basic
(piperazinyl) group, this makes these compounds
present as zwitterionic species at physiological pH.
 Like tetracyclines, they have chelating properties due
to the presence of β-diketo structure. They can form
stable, insoluble metal complexes with di and trivalent
metal ions:
 They should not be given along with antacids
and mineral supplements.
 formation of this chelate will reduce the
oral availability of these agents.
Chemical structure of
 Fluorine atom at C6 increases potency against gram –
ve bacteria.
 The piperazinyl group at C7 improves antipsuedomonal activity of Fluoroquinolones.
 Chelation also has another –ve effect: the possibility to
chelate with urine ions (Mg++ and Ca++) which leads to
Renal failure sometimes.
 Well absorbed following oral administration (90%).
 Well distributed through the body… reaches kidney,
prostate and cervix.
 Used mainly in prostatitis.
 40-50% excreted unchanged in urine.
 Highly distributed to all body fluids including CS fluid.
 Highly potent against gram –ve especially P. aeruginosa
 Used in gastroenteritis, skin, soft tissues (bone and joints)
infections and UTI.
 Has 1,4-oxazine ring.
 Has better penetration to CNS than ciprofloxacin
 The structure has asymmetric carbon atom, normally
ofloxacin is given as racemate, although the 3S(-)
isomer is 125x more active than the 3R(+) isomer.
 Recently the 3S(-) isomer (Levofloxacin)
has been prepared and now marketed
instead of ofloxacin which is more potent
(Chiral switching phenomenon)
 Has longer duration of action (t1/2 =7-8hrs), this is believed
to be due to:
 Excellent tissue distribution.
 Efficient renal reabsorption.
The only one that is given once daily.
It has an excellent oral bioavailability (98%).
Mainly used in acute bronchitis.
High incidence of phototoxicity due to the presence of two
fluorine atoms.
 Phototoxicity: is the formation of highly reactive oxygen
radicals due to the exposure to light.
 Higher potency against gram +ve
Staphylococcus and streptococcus bacteria.
 More active on anaerobic bacteria and Chlamydia.
 Long t1/2 (= 18hrs)
 Has the lowest incidence for phototoxicity.
New generation fluoroquinolones
 Gemifloxacin:
 is an oral broad-spectrum
quinolone antibacterial agent.
 Active against both gram +ve and gram –ve
bacteria except P. aeruginosa.
 used in the treatment of chronic bronchitis and mild-tomoderate pneumonia.
 Has a protein binding of 60-70%.
 Only 5-10% of the drug will be metabolized in the body
to give the N-acetyl and the glucuronide conjugate.
New generation fluoroquinolones
 Moxifloxacin:
 Considered a fourth generation quinolones.
 Given orally, parenterally and as eye
drops for treatment of conjunctivitis
 Uses:
Chronic bronchitis.
Acute bacterial sinusitis.
Skin infections.
 20% excreted unchanged in urine and 25% in feces.
 More than 50% of the drug metabolized to the sulfate and
glucuronide conjugates.